EUVIMEDObjevte EUVIMED
Video/Audio

N-Lactoyl-phenylalanine Improves Cardiac Function in a Mouse Model of Diabetic Cardiomyopathy by Regulating Lipid Metabolism

Zeyu Zhou, Xiaotong Yang, Wanyu Li, Xiaoli Liu, Xiaojian Wang, Shaojun Wu, Rong Gu

Journal of Visualized Experiments · 2026

DOI: 10.3791/72633 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Zeyu Zhou and 6 co-authors. Institution: Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine. Major MEDLINE topics: Diabetic Cardiomyopathies, Lipid Metabolism, Phenylalanine, Heart.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Diabetic cardiomyopathy (DCM) is one of the most serious complications of diabetes. N-lactoyl-phenylalanine (Lac-Phe), an endogenous metabolite, can promote weight loss and improve glucose homeostasis. This study sought to investigate the therapeutic effect of Lac-Phe on DCM and further explore the underlying mechanism. Type 2 diabetic mice with DCM were treated with Lac-Phe. Lac-Phe enhanced cardiac contractile function, ameliorated pathological remodeling, and reduced lipid accumulation in the heart. In vitro, the effects of Lac-Phe were investigated in H9c2 cells stimulated with high glucose and palmitic acid. Lac-Phe reduced lipid accumulation by decreasing cholesterol synthesis in H9c2 cells. Mechanistically, Lac-Phe promoted the phosphorylation and activation of adenosine monophosphate-activated protein kinase alpha 1 (AMPKα1). Subsequently, activated AMPKα1 phosphorylated and inhibited its downstream target, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), leading to reduced cholesterol synthesis and ultimately ameliorating lipid metabolism imbalance in H9c2 cells. These findings indicate that Lac-Phe improves lipid metabolism in H9c2 cells in DCM through the AMPKα1/HMGCR pathway, thereby enhancing cardiac contractile function and ameliorating pathological remodeling. Lac-Phe may represent a potential therapeutic approach for diabetic cardiomyopathy.

Subjects

MeSH terms (MEDLINE)

Diabetic CardiomyopathiesLipid MetabolismPhenylalanineHeartAnimalsMiceMaleCell LineDiabetes Mellitus, ExperimentalRatsMice, Inbred C57BLDisease Models, AnimalAMP-Activated Protein Kinases

Substances

PhenylalanineAMP-Activated Protein KinasesN-lactoyl-phenylalanine

Authors and institutions

  • Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine.
  • Affiliated Hospital of Medical School, Nanjing University.
  • Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Nanjing Tech University.
  • Affiliated Hospital of Medical School, Nanjing University; sjwu@cmu.edu.cn.
  • Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine; gurong.nju@163.com.

Cite

APA

Zhou, Z., Yang, X., Li, W., Liu, X., Wang, X., Wu, S., & Gu, R. (2026). N-Lactoyl-phenylalanine Improves Cardiac Function in a Mouse Model of Diabetic Cardiomyopathy by Regulating Lipid Metabolism. Journal of Visualized Experiments. https://doi.org/10.3791/72633

Vancouver

Zhou Z, Yang X, Li W, Liu X, Wang X, Wu S, et al. N-Lactoyl-phenylalanine Improves Cardiac Function in a Mouse Model of Diabetic Cardiomyopathy by Regulating Lipid Metabolism. Journal of Visualized Experiments. 2026. doi:10.3791/72633

BibTeX
@article{Zhou2026,
  author = {Zhou, Zeyu and Yang, Xiaotong and Li, Wanyu and Liu, Xiaoli and Wang, Xiaojian and Wu, Shaojun and Gu, Rong},
  title = {N-Lactoyl-phenylalanine Improves Cardiac Function in a Mouse Model of Diabetic Cardiomyopathy by Regulating Lipid Metabolism},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/72633}
}
Start for free →